Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
15
pubmed:dateCreated
2010-8-5
pubmed:abstractText
The synthesis and biological evaluation of potent and selective PKD inhibitors are described herein. The compounds described in the present study selectively inhibit PKD among other putative HDAC kinases. The PKD inhibitors of the present study blunt phosphorylation and subsequent nuclear export of HDAC4/5 in response to diverse agonists. These compounds further establish the central role of PKD as an HDAC4/5 kinase and enhance the current understanding of cardiac myocyte signal transduction. The in vivo efficacy of a representative example compound on heart morphology is reported herein.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1520-4804
pubmed:author
pubmed-author:BeattieKimberlyK, pubmed-author:BurgisRobinR, pubmed-author:CapparelliMichaelM, pubmed-author:ChapoJosephJ, pubmed-author:DipietroLucianL, pubmed-author:EnyedyIstvanI, pubmed-author:GamberGabrielG, pubmed-author:HoodDavid BDB, pubmed-author:HosagraharaVinayakV, pubmed-author:JewellCharlesC, pubmed-author:KochKeith AKA, pubmed-author:LemonDouglas DDD, pubmed-author:McKinseyTimothy ATA, pubmed-author:MeredithErik LEL, pubmed-author:MirandaKarlK, pubmed-author:MonovichLauren GLG, pubmed-author:PagratisNikosN, pubmed-author:PhanDillonD, pubmed-author:PlatoCraigC, pubmed-author:RaoChangC, pubmed-author:RozhitskayaOlgaO, pubmed-author:SoldermannNicolasN, pubmed-author:SpringerClaytonC, pubmed-author:VegaRichard BRB, pubmed-author:WentzR MRM, pubmed-author:YanWanlinW, pubmed-author:ZhuQingmingQ, pubmed-author:van EisMauriceM
pubmed:issnType
Electronic
pubmed:day
12
pubmed:volume
53
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5422-38
pubmed:meshHeading
pubmed-meshheading:20684592-2,2'-Dipyridyl, pubmed-meshheading:20684592-Active Transport, Cell Nucleus, pubmed-meshheading:20684592-Administration, Oral, pubmed-meshheading:20684592-Aminopyridines, pubmed-meshheading:20684592-Animals, pubmed-meshheading:20684592-Antihypertensive Agents, pubmed-meshheading:20684592-Blood Pressure, pubmed-meshheading:20684592-Cardiomegaly, pubmed-meshheading:20684592-Cell Nucleus, pubmed-meshheading:20684592-Histone Deacetylases, pubmed-meshheading:20684592-Isoenzymes, pubmed-meshheading:20684592-Male, pubmed-meshheading:20684592-Models, Molecular, pubmed-meshheading:20684592-Muscle Cells, pubmed-meshheading:20684592-Myocardium, pubmed-meshheading:20684592-Naphthyridines, pubmed-meshheading:20684592-Phosphorylation, pubmed-meshheading:20684592-Piperazines, pubmed-meshheading:20684592-Protein Binding, pubmed-meshheading:20684592-Protein Kinase C, pubmed-meshheading:20684592-Rats, pubmed-meshheading:20684592-Rats, Inbred Dahl, pubmed-meshheading:20684592-Rats, Sprague-Dawley, pubmed-meshheading:20684592-Structure-Activity Relationship
pubmed:year
2010
pubmed:articleTitle
Identification of potent and selective amidobipyridyl inhibitors of protein kinase D.
pubmed:affiliation
Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA. erik.meredith@novartis.com
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't